Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity
- 14 July 1978
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 201 (4351) , 171-173
- https://doi.org/10.1126/science.566468
Abstract
Long-term treatment of rats with haloperidol produced an increased sensitivity to the locomotor and stereotypic effect of apomorphine. This behavioral dopaminergic supersensitivity was accompanied by increased binding of [3H] spiroperidol in the striatum. Rats treated concurrently with lithium and haloperidol failed to develop both behavioral sensitivity to apomorphine and increased striatal dopamine receptor binding. The ability of lighium to prevent recurrent manicdepressive episodes may be related, in part, to its ability to stabilize dopaminergic receptor sensitivity.This publication has 19 references indexed in Scilit:
- Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptorsLife Sciences, 1977
- Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral SupersensitivityScience, 1977
- Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol of clozapineLife Sciences, 1977
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazineLife Sciences, 1976
- Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and α-methyl-p-tyrosineLife Sciences, 1975
- Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholaminesNeuropharmacology, 1974
- Behavioral evidence for dopaminergic supersensitivity after chronic haloperidolLife Sciences, 1974
- Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: Effects of apomorphine, l-DOPA, amantadine, amphetamine and other psychomotor stimulantsNeuropharmacology, 1973
- An experimental model of tardive dyskinesiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1972